Canagliflozin in Advanced Renal Disease With MRI Endpoints — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Canagliflozin in Advanced Renal Disease With MRI Endpoints — Stella

Recruiting

Back to ESRD, CKD Stage 4, CKD Stage 5 trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

McGill University Health Center, Montreal, Quebec

Key details

Phase

Safety & dosing

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborators

Heart and Stroke Foundation of Canada

Enrollment target

~92 participants

Started

May 2024

Primary completion

March 2028

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov